Related Experiment Video

Updated: Apr 9, 2026

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection
10:15

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection

Published on: November 10, 2021

2.3K

The role of thymosin-β4 in kidney disease

Elisavet Vasilopoulou1, Paul J D Winyard, Paul R Riley

  • 1UCL Institute of Child Health, Developmental Biology and Cancer , 30 Guilford Street, London, WC1N 1EH , UK +44 207 905 2615 ; +44 207 905 2133 ; d.long@ucl.ac.uk.

Expert Opinion on Biological Therapy
|June 23, 2015
PubMed

Insights

Thymosin-beta4, a natural peptide, shows promise for treating chronic kidney disease (CKD) by regulating inflammation and fibrosis. Its potential therapeutic benefits in CKD are being explored, building on existing clinical trials for other conditions.

Area of Science:

  • Biochemistry
  • Nephrology
  • Molecular Biology

Background:

  • Chronic kidney disease (CKD) is a major cause of morbidity and mortality.
  • Inflammation and fibrosis are key pathological processes in CKD progression.
  • Current therapies for CKD often focus on managing symptoms rather than addressing underlying mechanisms.

Discussion:

  • Thymosin-beta4 is a naturally occurring peptide with significant roles in cellular processes.
  • It acts as a major G-actin sequestering protein, influencing cell migration, proliferation, and survival.
  • Evidence suggests thymosin-beta4 possesses anti-inflammatory and anti-fibrotic properties.

Key Insights:

  • Thymosin-beta4's ability to modulate inflammation and fibrosis presents a potential therapeutic strategy for CKD.
  • Its established role in other conditions, like heart disease and wound healing, supports its investigation in kidney disease.
  • This peptide may offer a novel approach to halt or reverse CKD progression.

Outlook:

  • Further research is warranted to elucidate the precise mechanisms of thymosin-beta4 in the kidney.
  • Clinical trials investigating thymosin-beta4 for CKD could lead to new treatment paradigms.
  • Targeting inflammation and fibrosis with thymosin-beta4 may improve patient outcomes in chronic kidney disease.
Keywords:
Ac-SDKPfibrosisinflammationkidney diseasethymosin-β4

More Related Videos

Isolation of Double Negative αβ T Cells from the Kidney06:56

Isolation of Double Negative αβ T Cells from the Kidney

Published on: May 16, 2014

12.9K
Isolation and Transplantation of Different Aged Murine Thymic Grafts.05:47

Isolation and Transplantation of Different Aged Murine Thymic Grafts.

Published on: May 13, 2015

14.8K

Related Concept Videos

Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
2.0K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
996
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
724
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
637
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.2K
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
513